TITLE

CLS 2210, Hyaluronidase and the Cardiac Lymphatic System

AUTHOR(S)
Szlavy, L.; Kubik, S.; deCourten, A.; Hachen, H. J.; Solti, F.
PUB. DATE
July 1985
SOURCE
Angiology;Jul1985, Vol. 36 Issue 7, p452
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Earlier studies have shown that hyaluronidase exerts a potent influence upon the lymphatic system of the myocardium and that it reduces the size of myocardial infarcts after coronary occlusion. In this study we compared, in mongrel dogs, the effect of intravenous hyaluronidase or CLS 2210 upon the cardiac lymphatic vessels. We observed that in CLS 2210-treated animals the number of visualized cardiac lymphatic vessels was significantly higher than in the hyaluronidase- treated control group. We have previously demonstrated a cardio-protective effect of hyaluronidase in the treatment of acute myocardial infarction. The present experimental data indicate that intravenous CLS 2210 may have a definite role in the management of acute coronary occlusion. Further studies are needed to confirm these preliminary findings.
ACCESSION #
16352050

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics